… that stem cell therapy can be, at least, a complementary therapy to alleviate sufferings in
COVID-19 … This review discusses the possible therapeutic uses of MSCs for treating COVID-19. …

… Most countries are likely to have spread of COVID-19, at least in the early stages, … COVID-19
using stem cells, and how benefit might be scaled and simplified using synthetic stem cells …

… stem cell therapy in COVID-19, and registered COVID-19 clinical trials. Of all the stem
cell therapies touted for COVID-19 treatment, mesenchymal stem cells (MSCs) or MSC-like …

… The first reports of the use of allogeneic umbilical cord stem cells in a patient with COVID-19 …
The therapy was carried out on a 65-year-old patient with respiratory failure and COVID-19 …

… a confirmed COVID-19. Due to there is disagreement in MSCs therapy to treat COVID-19, …
information to researchers and enthusiasts of the stem cell-based therapy field. In this study, …

… , these cells secrete bioactive factors that are immunomodulatory and trophic, meaning
that these cells … Below we describe the mechanisms of action of mesenchymal stem cells (MSCs). …

… in severe or critical COVID-19 than those in SARS. Mesenchymal stem cells (MSCs), which
… As one of the most widely studied adult stem cells in regenerative medicine, MSCs produce …

… was performed on seven patients with COVID-19 infected pneumonia. The study was … of
mesenchymal stem cells for the treatment of pneumonitis caused by novel coronavirus” from …

… using the terms “Mesenchymal stem cells and COVID-19,” there were over 80 … of COVID-19
patients, along with the current progress and challenges of using MSCs to treat COVID-19, …

… the COVID-19 pandemic, novel alternative therapies may reduce the mortality rate. Recent
use of stem cells for critically ill COVID-19 … Use Authorization of stem cells by Food and Drug …